Celator Pharmaceuticals is now a subsidiary of Jazz Pharmaceuticals plc. Read more.

The companies share a focus on improving patients' lives and addressing unmet medical needs.

The combined team will build on the innovative development of Celator’s investigational pipeline and on Jazz’s proven expertise in hematology/oncology.

To learn more about Jazz Pharmaceuticals, please visit www.JazzPharmaceuticals.com.


Investors: investorinfo@jazzpharma.com

Media: mediainfo@jazzpharma.com

Careers: jazz.talent@jazzpharma.com

For Medical Information Requests related to Celator investigational products please call us at 1-800-520-5568 or email us at jazzpharma@medcomsol.com.

For Adverse Events/Drug Complaints related to Celator investigational products click here.

General Contacts: https://www.jazzpharma.com/contact/

Clinical sites may report adverse events by Fax to 609.243.0202.